CR6086 Uses, Dosage, Side Effects and more
CR6086 is under investigation in clinical trial NCT03163966 (A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in Dmard-naïve Patients With Early Rheumatoid Arthritis).
| Trade Name | CR6086 |
| Generic | CR6086 |
| Type | |
| Formula | C26H27F3N2O3 |
| Weight | Average: 472.508 Monoisotopic: 472.197377226 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
